Congress Expands Probe of Prescription-Drug Ads

WASHINGTON (AdAge.com) — The House Energy and Commerce Committee, which has been scrutinizing direct-to-consumer drug advertising for Pfizer's Lipitor, along with Vytorin, jointly marketed by Merck & Co. and Schering-Plough Corp., is expanding its probe to more drugs.

No Responses to “Congress Expands Probe of Prescription-Drug Ads”

Post a Comment